1.55
Schlusskurs vom Vortag:
$1.48
Offen:
$1.51
24-Stunden-Volumen:
68,907
Relative Volume:
0.06
Marktkapitalisierung:
$2.25M
Einnahmen:
$2,000
Nettoeinkommen (Verlust:
$-12.72M
KGV:
-0.0216
EPS:
-71.8121
Netto-Cashflow:
$-3.91M
1W Leistung:
-18.85%
1M Leistung:
-66.81%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Nexentis Technologies Inc Stock (NXTS) Company Profile
Firmenname
Nexentis Technologies Inc
Sektor
Branche
Telefon
972544561349
Adresse
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NXTS
Nexentis Technologies Inc
|
1.55 | 2.43M | 2,000 | -12.72M | -3.91M | -71.81 |
|
CTVA
Corteva Inc
|
89.34 | 58.58B | 17.89B | 1.26B | 2.05B | 1.7029 |
|
NTR
Nutrien Ltd
|
70.72 | 32.35B | 27.83B | 2.42B | 2.21B | 4.9113 |
|
CF
Cf Industries Holdings Inc
|
125.77 | 18.40B | 7.41B | 2.12B | 1.62B | 11.13 |
|
MOS
Mosaic Company
|
22.77 | 7.10B | 12.43B | 70.90M | -489.30M | 0.1275 |
|
ICL
Icl Group Ltd
|
5.18 | 6.65B | 7.41B | 314.00M | 220.88M | 0.202 |
Nexentis Technologies Inc Aktie (NXTS) Neueste Nachrichten
Nexentis subsidiary selects candidate for drug discovery program By Investing.com - Investing.com Canada
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign - Yahoo Finance
Nexentis Technologies Inc. Revenue Breakdown – NASDAQ:NXTS - TradingView
Nexentis Technologies Inc. SEC Filing (Jul 20, 2026) - Stock Titan
NXTS Q2 2025 Earnings: Reported Loss of $0.18 per Share Amid Market SelloffAnalyst Drop Coverage - dars.gov.et
Nexentis Technologies soars 156% before falling 46% after hours — here’s why NXTS stock is trending - MSN
Nexentis Technologies Inc. SEC Filing (Jul 16, 2026) - Stock Titan
Eun Young Lee holds 3.23% of Nexentis Technologies Inc. (NXTS) - Stock Titan
Nexentis Technologies files prospectus for 2.573M shares - scanx.trade
Nexentis Technologies (NASDAQ: NXTS) refreshes $100M shelf and details MitoCareX deal - Stock Titan
Nexentis Technologies registers to sell 2.57M shares of common stock for holders - TipRanks
Nexentis Technologies (NASDAQ: NXTS) registers 2.57M warrant shares for resale - Stock Titan
Nexentis Technologies Q2 2025 Earnings: Loss of -$0.18 Per Share Sends Stock Down 14.56%Quarterly Earnings Report - dars.gov.et
Nexentis Technologies (NXTS) Slides 4.5% as Selling Pressure Tests Key Support at $3.46Low Volume Node - dars.gov.et
NXTS Q2 2025 Earnings: Net Loss of $0.18 Per Share as Stock Slips 3.6%Earnings Quality Score - dars.gov.et
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative - The Manila Times
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter - GlobeNewswire
Nexentis unit maps more SLC proteins, then adds Boltz AI to hunt drug candidates - Stock Titan
NXTSNexentis Technologies Inc Earnings - Finviz
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis stock jumps on solar project monetization deal - Investing.com
Nexentis Announces Monetization of Part of It - Moomoo
NXTS Q2 2025 Earnings: A Disappointing Quarter as Losses Widen and Shares TumbleEarnings Yield Spread - dars.gov.et
Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS) - Yahoo Finance
Nexentis Technologies announces monetization of Melz solar investment - TipRanks
Nexentis receives partial loan repayment on German solar project By Investing.com - Investing.com Nigeria
Nexentis receives partial loan repayment on German solar project - Investing.com
Nexentis stock jumps on solar project monetization deal By Investing.com - Investing.com Canada
Nexentis Technologies Announces Addendum on Melz Solar Project Loan and Profit Rights, Reflecting $14.5 Million Project Valuation - Quiver Quantitative
Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment - Yahoo Finance
Nexentis monetizes Melz solar investment at $14.5 million valuation - scanx.trade
Price to sales forward of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Nexentis Technologies Inc NXTS-Q Earnings - The Globe and Mail
Enterprise value to revenue forward of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Enterprise value to EBITDA forward of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Price to earnings forward of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Price to book forward of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Nexentis Technologies Inc. (NXTS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Nexentis Technologies Inc (NXTS-Q) Insider Trade Summaries - The Globe and Mail
Nexentis Technologies Inc. Actuals & Estimates (NASDAQ:NXTS) - TradingView
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Narrowing Loss and Modest Stock UptickShare Repurchase Impact - dars.gov.et
Nexentis Technologies Announces Registered Direct Offering and Warrants - The Globe and Mail
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com
Crude Oil Down Over 1%; US Manufacturing PMI Surges In June - Benzinga
Nexentis Technologies Inc Offers 410,998 Shares At $7.056 Per ShareSEC Filing - TradingView
The market is filled with gapping stocks in Tuesday's session. - ChartMill
3 Penny Stocks to Watch Today, 6/23/2026 - TipRanks
Nexentis (NXTS) raises ~$2.9M via 410,998-share registered offering - Stock Titan
What's going on in today's pre-market session - ChartMill
6/22/2026 Market UpdateWinners: FCUV, NXTS, ADTXLosers: SDOT, SNBR, AEMDS&P 500: -0.4% - Trefis
Finanzdaten der Nexentis Technologies Inc-Aktie (NXTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):